Baidu
map

Circulation:急性冠脉综合征女性患者的住院死亡率明显高于男性患者!

2019-04-15 MedSci MedSci原创

冠心病是女性死亡的主要原因。急性冠状动脉综合征(ACS)是冠心病的一种急性表现,目前我国仍缺乏对急性冠状动脉综合征(ACS)住院女性的护理质量和预后的系统评价。

冠心病是女性死亡的主要原因。急性冠状动脉综合征(ACS)是冠心病的一种急性表现,目前我国仍缺乏对急性冠状动脉综合征(ACS)住院女性的护理质量和预后的系统评价。

CCC-ACS(改善中国血管疾病的护理—急性冠状动脉综合征)计划是美国心脏协会和中国心脏病学会开展的全国性研究。利用CCC-ACS计划的数据,研究人员对2014-2018年中国192家医院收治的82196位ACS患者在急性管理、二级预防医学治疗和住院死亡率方面的性别差异进行评估。

ACS女性患者的年龄要大于男性患者(69.0 vs 61.1岁,p<0.001),并发症也多于男性。经过多变量校正后,符合条件的女性进行ASC急性治疗的可能性低于男性,包括早期双重抗血小板疗法、住院期间的肝素治疗和ST段抬高型心肌梗死的再灌注治疗。至于二级预防,符合条件的女性进行双重抗血小板治疗、血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂、他汀类药物(出院后)、住院期间接受戒烟和心脏康复咨询的可能性较低。ACS女性患者的住院死亡率高于男性(2.60% vs 1.50%,P<0.001)。经临床特征和紧急治疗后,ST段抬高型心肌梗死患者和非ST段抬高型ACS的住院死亡率无性别差异。

在中国,女性ACS患者接受紧急治疗和二级预防治疗的比例远低于男性患者。住院死亡率的性别差异住院归因于较差的临床资料和提供给ACS女性的基于证据的紧急治疗较少。为了缩小ACS患者在护理质量和治疗预后方面的性别差异,有必要开展有针对不同性别的护理和治疗策略研究。

原始出处:

Yongchen Hao,et al.Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome.Circulation. Jan 22, 2019. https://doi.org/10.1161/CIRCULATIONAHA.118.037655

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2033528, encodeId=a3422033528ff, content=<a href='/topic/show?id=446044648ad' target=_blank style='color:#2F92EE;'>#女性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44648, encryptionId=446044648ad, topicName=女性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Oct 26 19:49:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054104, encodeId=a0e32054104ad, content=<a href='/topic/show?id=c699e024409' target=_blank style='color:#2F92EE;'>#男性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70244, encryptionId=c699e024409, topicName=男性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue Jun 25 18:49:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366166, encodeId=430913661663a, content=<a href='/topic/show?id=7d2f26450be' target=_blank style='color:#2F92EE;'>#住院死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26450, encryptionId=7d2f26450be, topicName=住院死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431487, encodeId=2bfc143148e78, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364725, encodeId=fed2364e25ca, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Tue Apr 16 07:06:53 CST 2019, time=2019-04-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2033528, encodeId=a3422033528ff, content=<a href='/topic/show?id=446044648ad' target=_blank style='color:#2F92EE;'>#女性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44648, encryptionId=446044648ad, topicName=女性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Oct 26 19:49:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054104, encodeId=a0e32054104ad, content=<a href='/topic/show?id=c699e024409' target=_blank style='color:#2F92EE;'>#男性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70244, encryptionId=c699e024409, topicName=男性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue Jun 25 18:49:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366166, encodeId=430913661663a, content=<a href='/topic/show?id=7d2f26450be' target=_blank style='color:#2F92EE;'>#住院死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26450, encryptionId=7d2f26450be, topicName=住院死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431487, encodeId=2bfc143148e78, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364725, encodeId=fed2364e25ca, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Tue Apr 16 07:06:53 CST 2019, time=2019-04-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2033528, encodeId=a3422033528ff, content=<a href='/topic/show?id=446044648ad' target=_blank style='color:#2F92EE;'>#女性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44648, encryptionId=446044648ad, topicName=女性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Oct 26 19:49:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054104, encodeId=a0e32054104ad, content=<a href='/topic/show?id=c699e024409' target=_blank style='color:#2F92EE;'>#男性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70244, encryptionId=c699e024409, topicName=男性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue Jun 25 18:49:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366166, encodeId=430913661663a, content=<a href='/topic/show?id=7d2f26450be' target=_blank style='color:#2F92EE;'>#住院死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26450, encryptionId=7d2f26450be, topicName=住院死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431487, encodeId=2bfc143148e78, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364725, encodeId=fed2364e25ca, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Tue Apr 16 07:06:53 CST 2019, time=2019-04-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2033528, encodeId=a3422033528ff, content=<a href='/topic/show?id=446044648ad' target=_blank style='color:#2F92EE;'>#女性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44648, encryptionId=446044648ad, topicName=女性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Oct 26 19:49:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054104, encodeId=a0e32054104ad, content=<a href='/topic/show?id=c699e024409' target=_blank style='color:#2F92EE;'>#男性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70244, encryptionId=c699e024409, topicName=男性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue Jun 25 18:49:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366166, encodeId=430913661663a, content=<a href='/topic/show?id=7d2f26450be' target=_blank style='color:#2F92EE;'>#住院死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26450, encryptionId=7d2f26450be, topicName=住院死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431487, encodeId=2bfc143148e78, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364725, encodeId=fed2364e25ca, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Tue Apr 16 07:06:53 CST 2019, time=2019-04-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2033528, encodeId=a3422033528ff, content=<a href='/topic/show?id=446044648ad' target=_blank style='color:#2F92EE;'>#女性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44648, encryptionId=446044648ad, topicName=女性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Oct 26 19:49:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054104, encodeId=a0e32054104ad, content=<a href='/topic/show?id=c699e024409' target=_blank style='color:#2F92EE;'>#男性患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70244, encryptionId=c699e024409, topicName=男性患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Tue Jun 25 18:49:00 CST 2019, time=2019-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366166, encodeId=430913661663a, content=<a href='/topic/show?id=7d2f26450be' target=_blank style='color:#2F92EE;'>#住院死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26450, encryptionId=7d2f26450be, topicName=住院死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db7c233, createdName=changjitao2009, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431487, encodeId=2bfc143148e78, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Apr 17 11:49:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364725, encodeId=fed2364e25ca, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Tue Apr 16 07:06:53 CST 2019, time=2019-04-16, status=1, ipAttribution=)]
    2019-04-16 183****7028

    学习

    0

相关资讯

JAMA Intern Med:非ST段抬高急性冠脉综合征应用低分子肝素等增大出血风险

广东省人民医院陈纪言、谭宁等在JAMA内科学发表文章称,对于接受冠脉介入治疗的非ST段抬高型急性冠状动脉综合征(NSTE-ACS)患者,在充分抗血小板治疗的基础上,应用低分子肝素和磺达肝素等肠外抗凝治疗,不会降低全因死亡或心梗的风险,反而显著增加严重出血的风险。

2019 专家建议:延长亚洲急性冠脉综合征患者双抗治疗

目前,大规模试验的新证据和指南的更新证实了急性冠脉综合征(ACS)患者延长双联抗血小板治疗的风险和获益。本文主要针对亚洲急性冠脉综合征患者双抗治疗的延长的几个危险因素提出了相应的建议。

Ann Rheum Dis:类风湿性关节炎患者同胞急性冠脉综合征的风险升高

RA患者的同胞出现ACS的风险升高,提示RA与ACS之间存在共同易感性。

Circ:Cardiovasc Inte:心源性休克发病率和结局的20年趋势

由于住院期间CS的减少,1997-2017年间CS的发病率下降。CS的院内死亡率从62.8%(1997年)下降到<40%(2017年)。

JACC:经导管主动脉瓣置换术后急性冠脉综合征的发病率、临床特征和影响

中位随访25个月后,约十分之一接受TAVR的患者因ACS再次入院。

葛均波:2018年介入心脏病年度盘点

转眼间一年就要过去了,现将2018年心血管介入治疗领域可能改变目前临床实践的重要研究和亮点研究回顾如下。

Baidu
map
Baidu
map
Baidu
map